000 01138 a2200325 4500
005 20250517024128.0
264 0 _c20150724
008 201507s 0 0 eng d
022 _a1432-0584
024 7 _a10.1007/s00277-015-2357-4
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGriesshammer, Martin
245 0 0 _aCurrent and future treatment options for polycythemia vera.
_h[electronic resource]
260 _bAnnals of hematology
_cJun 2015
300 _a901-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAnimals
650 0 4 _aAspirin
_xtherapeutic use
650 0 4 _aForecasting
650 0 4 _aHumans
650 0 4 _aInterferon-alpha
_xtherapeutic use
650 0 4 _aJanus Kinase 2
_xantagonists & inhibitors
650 0 4 _aPhlebotomy
_xtrends
650 0 4 _aPolycythemia Vera
_xdiagnosis
650 0 4 _aTreatment Outcome
700 1 _aGisslinger, Heinz
700 1 _aMesa, Ruben
773 0 _tAnnals of hematology
_gvol. 94
_gno. 6
_gp. 901-10
856 4 0 _uhttps://doi.org/10.1007/s00277-015-2357-4
_zAvailable from publisher's website
999 _c24765281
_d24765281